Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Insulin like growth factor binding protein 1 (IGFBP1) is a secreted circulating binding protein encoded by IGFBP1 gene, belonging to insulin-like growth factor binding protein family and acting as primary modulator of insulin-like growth factor bioavailability and peripheral tissue metabolic sensitivity. IGFBP1 is predominantly synthesized by hepatic and adipose tissue populations, carrying evolutionarily conserved IGF-binding N-terminal domains and C-terminal regulatory segments across species, serving as an essential modulator for IGF sequestration, release kinetics and target tissue signal accessibility. IGFBP1-mediated ligand binding exerts decisive effects on sustaining balanced IGF-dependent tissue growth, metabolic substrate utilization and insulin sensitivity under physiological conditions. Furthermore, IGFBP1 coordinates downstream signaling cascades governing glucose homeostasis, adipose tissue remodeling and hepatic endocrine output to safeguard intact systemic metabolic equilibrium. Distinct from other IGFBP family members with broader tissue distribution, IGFBP1 carries unique non-redundant roles in connecting hepatic secretion with peripheral IGF responsiveness, rendering it indispensable for normal metabolic adaptation, tissue insulin sensitivity and overall energy balance.
IGFBP1 executes biological functions through reversible high-affinity binding to circulating IGF molecules, forming stable complexes that restrict immediate receptor engagement while enabling controlled ligand release under changing metabolic conditions, thereby shaping the magnitude and duration of IGF-dependent signaling in target tissues. Its conserved binding domains mediate precise ligand capture and regulated dissociation, enabling fine-tuning of IGF bioavailability and metabolic signal transmission. IGFBP1-dependent signaling sustains systemic metabolic equilibrium, covering balanced IGF receptor activation cycles, coordinated glucose disposal and persistent insulin sensitivity surveillance. IGFBP1 participates in an extensive spectrum of biological processes, such as IGF ligand sequestration, adipose tissue remodeling, hepatic metabolic signaling and peripheral insulin response modulation. Dysregulated IGFBP1 secretion disturbs IGF bioavailability balance, alters tissue insulin responsiveness and elevates susceptibility to metabolic disorders, including insulin resistance and glucose intolerance. Therefore, IGFBP1 constitutes a pivotal research target for investigating metabolic endocrinology, insulin sensitivity and energy homeostasis pathogenic mechanisms.
Fig. 1 SAA inflammatory stimulus upregulates IGFBP-1 expression, which sequesters free IGF-1 and blocks IGF-1R-mediated cell proliferation signaling. Excess IGFBP-1 under inflammatory conditions elevates TXNIP levels and triggers cellular apoptosis compared with normal control group.1
The biological functions of IGFBP1 are focused on N-terminal domain-mediated IGF binding, circulating ligand buffering and peripheral tissue metabolic tuning:
Creative Biolabs offers high-quality IGFBP1 proteins via optimized expression systems, covering full-length IGFBP1 and isolated IGF-binding domain variants. These products retain native ligand-binding conformation and intrinsic IGF sequestration activity, suitable for protein-ligand interaction analysis, metabolic signal studies and metabolic disorder compound screening. All IGFBP1 proteins undergo rigorous quality control to guarantee consistent functional performance and reliable application across diverse research platforms.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides custom engineered IGFBP1 stable cell lines, including overexpression and gene silencing models. These cell line models are optimized for IGF signaling research, adipose metabolic phenotype and endocrine response profiling. Each cell line undergoes strict validation procedures to ensure steady target expression levels and uniform functional performance across multiple experimental scenarios.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
High-specificity recombinant antibodies targeting IGFBP1 are developed with advanced antibody engineering workflows, without cross-reactivity against other IGFBP family homologs. These antibodies receive multi-scenario functional validation, applicable to protein expression profiling, circulating secretion detection, IGF ligand binding assessment and metabolic research, enabling precise characterization of IGFBP1 expression patterns, systemic distribution and functional modulation under physiological and pathological states.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for IGFBP1 research:
IGFBP1 is a circulating IGF binding protein that sequesters IGF ligands, controls their bioavailability and modulates peripheral tissue insulin sensitivity.
IGFBP1 links hepatic endocrine output with peripheral IGF responsiveness; dysregulated expression impairs insulin sensitivity and metabolic balance, establishing it as a vital research target.
No, all IGFBP1 products and services are strictly for research use only, not intended for clinical diagnosis or treatment.
Offerings include IGFBP1 proteins, high-specificity recombinant antibodies and custom stable cell lines for metabolic homeostasis and insulin resistance research.
IGFBP1 proteins undergo functional verification via IGF ligand binding affinity assessment, binding domain conformational stability evaluation.
